From 'God's handwriting' to corporate profits

By Nathaniel Heller

Genome companies and their lawyers and lobbyists have locked up federal policy on human gene patenting with little public discussion

Related to this story

Massive backlog at patent office

By The Center for Public Integrity

State utility commissions fail transparency test

By John Dunbar and Leah Rush

Favorable logistics

By Claudio Julio Tognolli

Six Questions for Kendra Barkoff

Excerpts from this story referencing "Genomics":

"… for J. Craig Venter, the president and chief scientific officer of Celera Genomics Inc. of Rockville, Md. On June 26, Venter and the head of the Human Genome …"

"… lied close to $6 million in Akin, Gump receipts.Another competitor, Incyte Genomics Inc., of Palo Alto, Calif., also has a registered lobbyist, William Cloher …"